OTC:CASIF | Profit Breakdown | CASI Pharmaceuticals, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-12-31 to 2025-12-31
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$20.71M$10.08M-$45.01M-$45.87M-$48.06M
2024-12-31$28.54M$11.15M-$39.62M-$38.07M-$39.26M
2023-12-31$33.88M$20.05M-$25.08M-$26.29M-$26.96M
2022-12-31$38.05M$27.28M-$34.03M-$37.43M-$41.01M
2021-12-31$30.02M$17.61M-$41.52M-$35.84M-$36.65M
2020-12-31$15M$5.63M-$52.78M-$47.51M-$48.29M